n-acetylneuraminic acid has been researched along with zoledronic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Lai, X; Liu, M; Liu, X; Luo, X; Song, Y; Sui, D; Sun, W; Tang, X; Wang, S; Zhang, H; Zhao, D | 1 |
| Deng, Y; Ding, J; Liu, X; Qin, Y; Song, Y; Sui, D; Tang, X; Wang, Y; Zhang, N | 1 |
2 other study(ies) available for n-acetylneuraminic acid and zoledronic acid
| Article | Year |
|---|---|
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy.
Topics: Animals; Cell Line, Tumor; Humans; Immunotherapy; Macrophages; Mice; N-Acetylneuraminic Acid; Neoplasms; Sialic Acid Binding Immunoglobulin-like Lectins; Tumor Microenvironment; Tumor-Associated Macrophages; Zoledronic Acid | 2020 |
Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Epirubicin; Liposomes; Mice; N-Acetylneuraminic Acid; Zoledronic Acid | 2021 |